Factor V Leiden and other coagulation factor mutations affecting thrombotic risk

Clinical Chemistry

Volumn 43, Issue 9, 1997, Pages 1678-1683

  Bertina, Rogier M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5;

CONFERENCE PAPER; DIAGNOSTIC VALUE; DNA DETERMINATION; GENE MUTATION; HUMAN; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK ASSESSMENT; VEIN THROMBOSIS;

EID: 0030870825     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.9.1678     Document Type: Conference Paper

References (42)

1. Beck EA, Charache P, Jackson DP. A new inherited coagulation disorder caused by abnormal fibrinogen (fibrinogen Baltimore). Nature 1965;208:143-5.
2. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 1995;73:151-61.
3. Egeberg O. Inherited antithrombin III deficiency causing thrombophilia. Thromb Diath Haembrrh 1967;13:516-30.
4. Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol 1981;10:369-90.
5. Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein Sb, Cooper DN, et al. Antithrombin mutation database: first update. Thromb Haemost 1993;70:361-9.
6. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: Part I. Thromb Haemost 1996;76:651-62.
7. Griffin JH, Evatt B, Zimmerman TS, Kleis AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-3.
8. Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993;341:134-8.
9. Marlar RA, Montgomery R, Broekmans AW. Diagnosis and treatment of homozygous protein C deficiency. J Pediatr 1989;114: 528-34.
10. Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, et al. Protein C deficiency: a database of mutations, 1995 update. Thromb Haemost 1995;73:876-89.
11. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984;74:2082-8.
12. Engesser L, Broekmans AW, Briët E, Brommer EJP, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987;106:677-82.
13. Aiach M, Gandrille S, Emmerich J. A review of mutations causing deficiencies of antithrombin, protein C and protein S. Thromb Haemost 1995;74:81-9.
14. Koster T, Rosendaal FR, Briët E, van der Meer FJ, Colly LP, Trienekens PH, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995; 85:2756-61.
15. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
16. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
17. Tait RC, Walker ID, Islam SIAM, McCall F, Conkie JA, Wight M, et al. Protein C activity in healthy volunteers-influence of age, sex, smoking and oral contraceptives. Thromb Haemost 1993;70: 281-3.
18. Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261:12022-7.
19. Zöller B, Garcio de Frutos B, Dahlbäck B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrates type I and type II deficiencies to be phenotypic variants of the same genetic disease. Blood 1995;85:3524-31.
20. Faioni EM, Franchi F, Asti D, Sacchi E, Bernardi F, Mannucci PM. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost 1993;70:1067-71.
21. Ortega IS, Pinto CR, Urgelles MF, Luengo JR. Influence of protein C resistance (APC-R) on the determination of protein C and S by functional clotting assays. Blood Coagul Fibrinolysis 1995;6: 683-7.
22. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previous unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sei U S A 1993;90:1004-8.
23. Griffin JH, Evatt B, Wideman G, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993;82:1989-93.
24. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated C: Leiden Thrombophilia Study. Lancet 1993; 342:1503-6.
25. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995;74:449-53.
26. Kalafatis M, Bertina RM, Rand MD, Mann KG. Characterization of the molecular defect in factor V R506Q. J Biol Chem 1995;270: 4053-7.
27. Nicolaes GAF, Tans G, Thomassen MCLGD, Hemker HC, Pabinger I, Varadi K, et al. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor Va R506Q by activated protein C. J Biol Chem 1995;270:21158-66.
28. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
29. Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner B, et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997;89:397-402.
30. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (APC resistance). Blood 1995;85:1505-8.
31. Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekes CH. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation 1995;92:2800-2.
32. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood 1994;84:1031-5.
33. Zöller B, Berntsdoller A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995;85:3518-23.
34. van Boven H, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, et al. Factor V Leiden in families with inherited antithrombin deficiency. Thromb Haemost 1996;75:417-21.
35. de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994;72:880-6.
36. Tripodi A, Negri B, Bertina RM, Mannucci PM. Screening for the FV: Q506 mutation-evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis. Thromb Haemost 1997;77:436-9.
37. Legnani C, Palareti G, Biagi R, Coccheri S, Bernardi F, Rosendaal FR, et al. Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation. Br J Haematol 1996;93:694-9.
38. Jorguera JI, Aznar J, Femandez MA, Montoro JM, Curats R, Casaña P. A modification of the APC-resistance test and its application to the study of patients on coumarin therapy. Thromb Res 1996;82: 217-24.
39. Ahlenc-Gelas M, Aillaud MF, Bonvarlet MM, Dupuy G, Juhan-Vague I, Aiach M. Specificity of an assay based on a factor V-depleted plasma in patients carrying the Arg506 Gin mutation. Thromb Haemost 1996;75:971-7.
40. Nicolaes GAF, Thomassen MCLGD, van Oerle R, Hamalyak K, Hemker HC, Tans G, Rosing J. A prothrombinase-based assay for detection of resistance to activated protein C. Thromb Haemost 1996;76:404-10.
41. Reitsma PH, van der Velden PH, Vogels E, van Strijp D, Tacker N, Adriaansen H, van Gemen B. Use of direct RNA amplification technique NASBA to detect factor V Leiden, a point mutation associated with APC-resistance. Blood Coagul Fibrinolysis 1996; 7:659-63.
42. Liebman HA, Sutherland D, Bacon R, McGehee W. Evaluation of a tissue factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance. Br J Haematol 1996;95:550-3.